FTC Docket C-3979

novartisletter

Last amended: 2000Year: 2000Length: 154 wordsOfficial source
UNITED STATES OF AMERICA FEDERAL TRADE COMMISSION WASHINGTON, D.C. 20580 Office of the Secretary December 6, 2000 Kenneth S. Prince, Esq. Shearman & Sterling 599 Lexington Avenue New York, NY 10022-6069 Ronan P. Harty, Esq. Davis Polk & Wardwell 450 Lexington Avenue New York, NY 10017 Re: Proposed Merger of AstraZeneca PLC's Agricultural Chemicals Business With Novartis AG's Agricultural Chemicals and Seeds Businesses, File No. 001-0082 Dear Mr. Prince and Mr. Harty: This is to notify you that, pursuant to Paragraph IV of the Order to Maintain Assets contained in the Agreement Containing Consent Orders for In the Matter of Novartis AG et al., File No. 001-0092, the Federal Trade Commission has appointed Richard Gilmore as Monitor Trustee and has approved the trust agreement executed by respondents and Mr. Gilmore. By direction of the Commission. Donald S. Clark Donald S. Clark Secretary cc: Richard Gilmore The GIC Group 1016 Duke Street Alexandria, VA 22314
FTC Docket C-3979: novartisletter | Justis AI